{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T15:26:01Z","timestamp":1791127561534,"version":"4.1.0"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1097\/wnf.0b013e3181d479e0","type":"journal-article","created":{"date-parts":[[2010,4,8]],"date-time":"2010-04-08T02:53:47Z","timestamp":1270695227000},"page":"158-160","source":"Crossref","is-referenced-by-count":63,"title":["Iatrogenic Botulism After Botulinum Toxin Type A Injections"],"prefix":"10.1097","volume":"33","author":[{"given":"Arzu","family":"Coban","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeliha","family":"Matur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasmet A.","family":"Hanagasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yesim","family":"Parman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-10-20210203","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1212\/WNL.40.9.1332","article-title":"Assessment: the clinical usefulness of botulinum toxin-A in treating neurologic disorders.","volume":"40","year":"1990","journal-title":"Neurology"},{"key":"R2-10-20210203","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/(SICI)1097-4598(1997)6+<146::AID-MUS10>3.0.CO;2-4","article-title":"Botulinum toxin: chemistry, pharmacology, toxicity, and immunology.","volume":"6","author":"Brin","year":"1997","journal-title":"Muscle Nerve Suppl"},{"key":"R3-10-20210203","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1212\/WNL.38.11.1780","article-title":"Neuromuscular effects distant from the site of botulinum neurotoxin injection.","volume":"38","author":"Olney","year":"1988","journal-title":"Neurology"},{"key":"R4-10-20210203","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1136\/jnnp.67.1.90","article-title":"Generalised muscular weakness after botulinum toxin injections for dystonia: a report of three cases.","volume":"67","author":"Bhatia","year":"1999","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R5-10-20210203","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1136\/jnnp.62.2.198","article-title":"Generalized botulism-like syndrome after intramuscular injections of botulinum toxin type A: a report of two cases.","volume":"62","author":"Bakheit","year":"1997","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R6-10-20210203","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1002\/mds.20903","article-title":"Iatrogenic botulism in an amateur weight-lifter.","volume":"21","author":"Duffey","year":"2006","journal-title":"Mov Disord"},{"key":"R7-10-20210203","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1212\/01.wnl.0000244417.34846.b6","article-title":"Severe botulism after focal injection of botulinum toxin.","volume":"67","author":"Souayah","year":"2006","journal-title":"Neurology"},{"key":"R8-10-20210203","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1001\/jama.296.20.2476","article-title":"Botulism in 4 adults following cosmetic injections with an unlicensed, highly concentrated botulinum preparation.","volume":"296","author":"Chertow","year":"2006","journal-title":"JAMA"},{"key":"R9-10-20210203","doi-asserted-by":"crossref","first-page":"95","DOI":"10.4103\/0974-2077.44169","article-title":"Botulinum toxin deaths: what is the fact?","volume":"1","author":"Omprakash","year":"2008","journal-title":"J Cutan Aesthet Surg"},{"key":"R10-10-20210203","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0037-6337(08)70222-5","article-title":"New botulinum toxin injection warnings issued: postinjection symptoms include dysphagia, ptosis and shortness of breath, according to the FDA.","volume":"39","author":"Ault","year":"2008","journal-title":"Skin Allergy News"},{"key":"R12-10-20210203","doi-asserted-by":"crossref","first-page":"221","DOI":"10.7326\/0003-4819-129-3-199808010-00011","article-title":"Botulism in the United States: a clinical and epidemiologic review.","volume":"129","author":"Shapiro","year":"1998","journal-title":"Ann Intern Med"},{"key":"R13-10-20210203","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1002\/(SICI)1097-4598(199806)21:6<701::AID-MUS1>3.0.CO;2-B","article-title":"Clinical spectrum of botulism.","volume":"21","author":"Cherington","year":"1998","journal-title":"Muscle Nerve"},{"key":"R14-10-20210203","doi-asserted-by":"crossref","first-page":"442","DOI":"10.7326\/0003-4819-95-4-442","article-title":"Clinical features of types A and B food-borne botulism.","volume":"95","author":"Hughes","year":"1981","journal-title":"Ann Intern Med"},{"key":"R15-10-20210203","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1136\/jnnp.55.9.844","article-title":"Botulinum toxin therapy: distant effects on neuromuscular transmission and autonomic nervous system.","volume":"55","author":"Girlanda","year":"1992","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R16-10-20210203","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/mds.870080106","article-title":"Time course of distant effects of local injections of botulinum toxin.","volume":"8","author":"Garner","year":"1993","journal-title":"Mov Disord"},{"key":"R17-10-20210203","first-page":"517","article-title":"Local injection treatment with botulinum toxin A in severe arm and leg spasticity.","volume":"64","author":"Konstanzer","year":"1993","journal-title":"Nervenarzt"},{"key":"R18-10-20210203","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1136\/bmj.320.7228.161","article-title":"Regular review: uses of botulinum toxin injection in medicine today.","volume":"320","author":"Munchau","year":"2000","journal-title":"BMJ"},{"key":"R19-10-20210203","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/17429590701523794","article-title":"Diffusion characteristics of botulinum neurotoxin products and their clinical significance in cosmetic applications.","volume":"9","author":"De Almeida","year":"2007","journal-title":"J Cosmet Laser Ther"},{"key":"R20-10-20210203","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1468-1331.2006.01438.x","article-title":"Pharmacology of botulinum toxin: differences between type A preparations.","volume":"13","author":"Rosales","year":"2006","journal-title":"Eur J Neurol"},{"key":"R21-10-20210203","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/BF03033931","article-title":"Botulinum neurotoxin-from laboratory to bedside.","volume":"9","author":"Foster","year":"2006","journal-title":"Neurotoxicity Res"},{"key":"R22-10-20210203","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1001\/archneur.1991.00530240057020","article-title":"Clinical correlates of response to botulinum toxin injections.","volume":"48","author":"Jankovic","year":"1991","journal-title":"Arch Neurol"}],"container-title":["Clinical Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00002826-201005000-00010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:13:54Z","timestamp":1786040034000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002826-201005000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/wnf.0b013e3181d479e0","relation":{},"ISSN":["0362-5664"],"issn-type":[{"value":"0362-5664","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]}}}